2.9000
+0.1270
+(4.58%)
At close: January 10 at 3:30:58 PM GMT+1
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 10 | 2 | 10 | 9 |
| Avg. Estimate | 7.58M | 13.97M | 31.58M | 43.34M |
| Low Estimate | 4.35M | 5.36M | 28.13M | 19M |
| High Estimate | 11.74M | 22.57M | 37M | 96.07M |
| Year Ago Sales | 9.2M | 9.95M | 38.02M | 31.58M |
| Sales Growth (year/est) | -17.62% | 40.33% | -16.95% | 37.25% |
EPS Trend
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| 8QQ.F | -- | -- | -- | -- |
| S&P 500 | 8.70% | 11.55% | 14.03% | 13.42% |
Upgrades & Downgrades
| Maintains | Keybanc: Overweight to Overweight | 1/8/2025 |
| Reiterates | Benchmark: Hold | 11/5/2024 |
| Reiterates | Stifel: Buy to Buy | 11/5/2024 |
| Downgrade | Benchmark: Buy to Hold | 8/20/2024 |
| Maintains | Keybanc: Overweight to Overweight | 7/11/2024 |
| Maintains | Keybanc: Overweight to Overweight | 5/8/2024 |
Related Tickers
YB4P.MU Savara Inc
2.9800
0.00%
A1SN34.SA Ascendis Pharma A/S
58.44
0.00%
0QAJ.IL DBV Technologies S.A.
0.8715
-22.19%
FYB.F Formycon AG
62.50
+1.63%
IPHA Innate Pharma S.A.
1.7700
-1.67%
22UA.F BioNTech SE
120.20
+1.52%
DBV.PA DBV Technologies S.A.
0.8750
-23.91%
SVRA Savara Inc.
2.7800
-8.55%
RPTX Repare Therapeutics Inc.
1.3800
+7.81%
DBVT DBV Technologies S.A.
4.9700
+29.77%